-

ADXS Investor Alert – Monteverde & Associates PC and Kahn Swick & Foti, LLC Obtain Material Disclosures Regarding the Upcoming Shareholder Vote for Advaxis, Inc. - ADXS

NEW YORK--(BUSINESS WIRE)--Kahn Swick & Foti, LLC and Monteverde & Associates PC announce that, on March 28, 2022, Advaxis, Inc. issued a Supplemental Proxy Statement that includes additional clarifying information about how to vote regarding Proposal No. 1 (the Reverse Stock Split), which will be voted on at the Special Meeting of Stockholders scheduled for March 31, 2022.

We urge shareholders to review the Supplemental Proxy Statement. Information about it is located here: https://www.ksfcounsel.com/news/material-disclosures-advaxis/.

The Supplemental Proxy Statement issued on March 28, 2022 is located here: https://www.sec.gov/Archives/edgar/data/0001100397/000149315222007816/defa14a.htm.

The Definitive Proxy Statement is located here: https://www.advaxis.com/sec-filings/sec-filing/def-14a/0001493152-22-005564

As a reminder, the Special Meeting will be held entirely online. You will be able to attend and participate in the Special Meeting online by visiting http://www.virtualshareholdermeeting.com/ADXS2022SM on March 31, 2022, beginning at 10:00 am, local time.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

Attorney Advertising. The law firms responsible for this advertisement are Monteverde & Associates PC and Kahn Swick & Foti, LLC. Prior results do not guarantee a similar outcome with respect to any future matter.

Contacts

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Kahn Swick & Foti, LLC

OTCQX:ADXS

Release Versions

Contacts

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Ultragenyx who were adversely affected by alleged securities fraud between August 3, 2023 and December 26, 2025. Follow the li...

Eventbrite Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eventbrite, Inc. - EB

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Eventbrite, Inc. (NYSE: EB) to Bending Spoons. Under the terms of the proposed transaction, shareholders of Eventbrite will receive $4.50 in cash for each share of Eventbrite that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether...

RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RAPT Therapeutics, Inc. (NasdaqGM: RAPT) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of RAPT will receive $58.00 in cash for each share of RAPT that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or...
Back to Newsroom